Frances E. Broyles

434 total citations
10 papers, 211 citations indexed

About

Frances E. Broyles is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Frances E. Broyles has authored 10 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 2 papers in Physiology. Recurrent topics in Frances E. Broyles's work include Lipoproteins and Cardiovascular Health (4 papers), Pituitary Gland Disorders and Treatments (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Frances E. Broyles is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Pituitary Gland Disorders and Treatments (3 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). Frances E. Broyles collaborates with scholars based in United States, Italy and Canada. Frances E. Broyles's co-authors include Robert H. Knopp, Barbara S. McCann, John J. Albers, M. Scott Magee, Santica M. Marcovina, Marian C. Cheung, Wayne L. Chandler, Katherine H. Moore, Donald B. Hunninghake and J. Fröhlich and has published in prestigious journals such as The American Journal of Medicine, Journal of neurosurgery and The American Journal of Cardiology.

In The Last Decade

Frances E. Broyles

10 papers receiving 201 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frances E. Broyles United States 7 117 110 42 32 28 10 211
Priya Manjoo Canada 8 117 1.0× 43 0.4× 22 0.5× 38 1.2× 20 0.7× 12 223
А. В. Зилов Russia 8 185 1.6× 53 0.5× 21 0.5× 24 0.8× 24 0.9× 35 325
Francisco Fernández-Vega Spain 9 71 0.6× 23 0.2× 95 2.3× 17 0.5× 6 0.2× 19 196
Xiaojun Luan China 8 204 1.7× 86 0.8× 79 1.9× 18 0.6× 10 0.4× 11 343
Gemma Carreras Spain 11 189 1.6× 117 1.1× 46 1.1× 20 0.6× 18 0.6× 12 345
Emilie Duchêne France 10 167 1.4× 180 1.6× 53 1.3× 26 0.8× 5 0.2× 11 323
Zimin Song China 11 54 0.5× 41 0.4× 57 1.4× 74 2.3× 10 0.4× 38 306
K Dolezalová Czechia 8 69 0.6× 250 2.3× 19 0.5× 10 0.3× 26 0.9× 17 308
F. Sayegh Argentina 5 141 1.2× 24 0.2× 30 0.7× 46 1.4× 2 0.1× 6 267
Ronald I. Harris United States 6 187 1.6× 16 0.1× 14 0.3× 19 0.6× 68 2.4× 7 325

Countries citing papers authored by Frances E. Broyles

Since Specialization
Citations

This map shows the geographic impact of Frances E. Broyles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances E. Broyles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances E. Broyles more than expected).

Fields of papers citing papers by Frances E. Broyles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frances E. Broyles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances E. Broyles. The network helps show where Frances E. Broyles may publish in the future.

Co-authorship network of co-authors of Frances E. Broyles

This figure shows the co-authorship network connecting the top 25 collaborators of Frances E. Broyles. A scholar is included among the top collaborators of Frances E. Broyles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frances E. Broyles. Frances E. Broyles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Mayberg, Marc R., et al.. (2017). Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing’s disease: implications for immediate reoperation and remission. Journal of neurosurgery. 129(5). 1268–1277. 26 indexed citations
2.
Moisi, Marc, Aurora Cruz, Tara Benkers, et al.. (2016). Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas with Adjuvant Temozolomide Chemotherapy: A Review. Cureus. 8(6). e658–e658. 9 indexed citations
3.
Ludlam, W.H., et al.. (2016). Diagnosis of Cushing's disease in a patient with consistently normal urinary free cortisol levels: a case report. Clinical Case Reports. 4(12). 1181–1183. 1 indexed citations
4.
Knopp, Robert H., Frances E. Broyles, Marian C. Cheung, et al.. (2001). Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel. Contraception. 63(1). 1–11. 43 indexed citations
5.
Heinonen, Therèse, Helmut G. Schrott, James M. McKenney, et al.. (1996). Atorvastatin, a New HMG-CoA Reductase Inhibitor as Monotherapy and Combined With Colestipol. Journal of Cardiovascular Pharmacology and Therapeutics. 1(2). 117–122. 23 indexed citations
6.
Knopp, Robert H., et al.. (1996). EFFECT OF PRAVASTATIN IN THE TREATMENT OF PATIENTS WITH TYPE III HYPERLIPOPROTEINEMIA. American Journal of Therapeutics. 3(11). 755–762. 5 indexed citations
7.
McCann, Barbara S., et al.. (1995). Acute Psychological Stress and Epinephrine Infusion in Normolipidemic and Hyperlipidemic Men. Psychosomatic Medicine. 57(2). 165–176. 46 indexed citations
8.
Broyles, Frances E., et al.. (1995). Effect of fluvastatin on intermediatedensity Lipoprotein (remnants) and other lipoprotein levels in hypercholestarolemia. The American Journal of Cardiology. 76(1-2). 129A–135A. 25 indexed citations
9.
Knopp, Robert H., J. Fröhlich, Keith Dawson, et al.. (1994). Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia. The American Journal of Medicine. 96(6). S69–S78. 31 indexed citations
10.
Heinonen, Therèse, et al.. (1994). The lipid-lowering effects of atorvastatin and colestipol used as monotherapies and in combination. Atherosclerosis. 109(1-2). 314–314. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026